These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30552464)

  • 21. Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.
    Dimitrijevic D; Fabian E; Funk-Weyer D; Landsiedel R
    Biochem Biophys Res Commun; 2023 Apr; 651():114-120. PubMed ID: 36812744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
    Delclos KB; Newbold R
    Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
    Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
    Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced prediction of internal concentrations of phenolic endocrine disrupting chemicals and their metabolites in fish by a physiologically based toxicokinetic incorporating metabolism (PBTK-MT) model.
    Liu YH; Yao L; Huang Z; Zhang YY; Chen CE; Zhao JL; Ying GG
    Environ Pollut; 2022 Dec; 314():120290. PubMed ID: 36180004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of new alternative methods for the identification of estrogenic, androgenic and steroidogenic effects: a comparative in vitro/in silico study.
    Najjar A; Wilm A; Meinhardt J; Mueller N; Boettcher M; Ebmeyer J; Schepky A; Lange D
    Arch Toxicol; 2024 Jan; 98(1):251-266. PubMed ID: 37819454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.
    Wang S; Rijk JC; Besselink HT; Houtman R; Peijnenburg AA; Brouwer A; Rietjens IM; Bovee TF
    Toxicol Sci; 2014 Sep; 141(1):78-89. PubMed ID: 24928889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate.
    Wambaugh JF; Setzer RW; Pitruzzello AM; Liu J; Reif DM; Kleinstreuer NC; Wang NC; Sipes N; Martin M; Das K; DeWitt JC; Strynar M; Judson R; Houck KA; Lau C
    Toxicol Sci; 2013 Dec; 136(2):308-27. PubMed ID: 24046276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.
    Bessems JG; Loizou G; Krishnan K; Clewell HJ; Bernasconi C; Bois F; Coecke S; Collnot EM; Diembeck W; Farcal LR; Geraets L; Gundert-Remy U; Kramer N; Küsters G; Leite SB; Pelkonen OR; Schröder K; Testai E; Wilk-Zasadna I; Zaldívar-Comenges JM
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):119-39. PubMed ID: 24287156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of in vivo assays for endocrine disruption.
    Clode SA
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects of Mono-(2-Ethylhexyl) Phthalate (MEHP) on Human Estrogen Receptor (hER) and Androgen Receptor (hAR) by YES/YAS In Vitro Assay.
    Kim DH; Park CG; Kim SH; Kim YJ
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine disrupters--testing strategies to assess human hazard.
    Baker VA
    Toxicol In Vitro; 2001; 15(4-5):413-9. PubMed ID: 11566572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations.
    Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F
    Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol.
    Frizzell C; Ndossi D; Kalayou S; Eriksen GS; Verhaegen S; Sørlie M; Elliott CT; Ropstad E; Connolly L
    Toxicol Appl Pharmacol; 2013 Aug; 271(1):64-71. PubMed ID: 23665424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ability of the YAS and AR CALUX assays to detect the additive effects of anti-androgenic fungicide mixtures.
    Seeger B; Klawonn F; Bekale BN; Steinberg P
    Toxicol Lett; 2016 Jan; 241():193-9. PubMed ID: 26602169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.
    Miller MM; McMullen PD; Andersen ME; Clewell RA
    Crit Rev Toxicol; 2017 Aug; 47(7):564-580. PubMed ID: 28675057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorpyrifos: weight of evidence evaluation of potential interaction with the estrogen, androgen, or thyroid pathways.
    Juberg DR; Gehen SC; Coady KK; LeBaron MJ; Kramer VJ; Lu H; Marty MS
    Regul Toxicol Pharmacol; 2013 Aug; 66(3):249-63. PubMed ID: 23524272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
    Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
    Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB
    Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and Optimization of Pharmacokinetic Models for
    Casey WM; Chang X; Allen DG; Ceger PC; Choksi NY; Hsieh JH; Wetmore BA; Ferguson SS; DeVito MJ; Sprankle CS; Kleinstreuer NC
    Environ Health Perspect; 2018 Sep; 126(9):97001. PubMed ID: 30192161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.